| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/06/2004 | US6716612 Modifying the branching degree of amylopectin synthesized in plants, |
| 04/06/2004 | US6716609 Enzymatic polypeptide for use in the generation of 2-pyrone-4,6-dicarboxylic acid |
| 04/06/2004 | US6716608 Artificial chromosome |
| 04/06/2004 | US6716607 Chicken interferon gene and novel recombinant DNA |
| 04/06/2004 | US6716606 For use in hematopoietic therapy; for arresting proliferation of leukemic cells |
| 04/06/2004 | US6716604 Calcium/calmodulin-dependent protein kinase peptide for treatment of arteriosclerosis and psoriasis; antiinflammatory/anticarcinogeneic agents |
| 04/06/2004 | US6716603 Nucleic acids encoding a chloride channel protein |
| 04/06/2004 | US6716602 Metabolic rate shifts in fermentations expressing recombinant proteins |
| 04/06/2004 | US6716601 Controlling the expression of homologous and heterologous nucleic acid molecules in yeast cells. |
| 04/06/2004 | US6716598 Isolating adjusted polypeptide; obtain sample, incubate with binding agent, filter mixture, remove leaching agent, isolate polypeptide |
| 04/06/2004 | US6716587 Antiinflammatory |
| 04/06/2004 | US6716586 Insulin-like growth factor agonist molecules |
| 04/06/2004 | US6716585 Detecting genes associated with controlling angiogenesis; obtain and culture endothelial cells, isolate ribonucleic acids, amplified or reduced concentrations of preferenial ribonucleic acids indicate association with angiogenesis |
| 04/06/2004 | US6716583 Methods of producing nucleic acid ligands |
| 04/06/2004 | US6716582 Cellular arrays for the identification of altered gene expression |
| 04/06/2004 | US6716580 Method for the automated generation of nucleic acid ligands |
| 04/06/2004 | US6716575 Diagnosis and treatment of AUR1 and/or AUR2 related disorders |
| 04/06/2004 | US6716474 Expression of fructose 1,6 bisphosphate aldolase in transgenic plants |
| 04/06/2004 | US6716431 Rotavirus nonstructural protein 4 in which histidine or asparagine at amino acid position 47 is mutagenized to aspartic acid to produce alternative form which has reduced toxicity, while retaining its antigenicity and immunogenicity |
| 04/06/2004 | US6716430 Moderating immunology response |
| 04/06/2004 | CA2390009C Flow cell for synthesis of arrays of dna probes and the like |
| 04/06/2004 | CA2269077C Keratinocyte growth factor-2 products |
| 04/06/2004 | CA2257122C Method of activating denatured protein |
| 04/06/2004 | CA2196296C Production of tissue factor pathway inhibitor |
| 04/06/2004 | CA2174140C Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions |
| 04/06/2004 | CA2147372C Multidrug resistance gene |
| 04/06/2004 | CA2089563C Oligonucleotide modulation of cell adhesion |
| 04/06/2004 | CA2085232C Xylanase production |
| 04/06/2004 | CA2042016C Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 04/06/2004 | CA2010321C Lymphocyte-associated cell surface protein |
| 04/03/2004 | CA2442521A1 Repressor-mediated selection strategies |
| 04/02/2004 | WO2004031372A1 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
| 04/02/2004 | CA2435274A1 Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity |
| 04/02/2004 | CA2406304A1 Biological selection system |
| 04/01/2004 | WO2004027384A2 Real-time detection of nucleic acid reactions |
| 04/01/2004 | WO2004027092A2 Dna chips used for bioprocess control |
| 04/01/2004 | WO2004027075A2 Chemoenzymatic methods for the synthesis of statins and stain intermediates |
| 04/01/2004 | WO2004027073A1 Modified adenoviral vectors for use in vaccines and gene therapy |
| 04/01/2004 | WO2004027072A2 Method for making recombinant proteins |
| 04/01/2004 | WO2004027071A1 Method of producing and screening antibodies produced in transgenic plants |
| 04/01/2004 | WO2004027070A2 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 04/01/2004 | WO2004027069A1 Transgenic expression cassettes for the expression of nucleic acids in plant blooms |
| 04/01/2004 | WO2004027068A2 Systems for expressing toxic proteins, vectors and method of producing toxic proteins |
| 04/01/2004 | WO2004027067A2 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 04/01/2004 | WO2004027066A2 Chimeric recombinant protein and in vitro diagnosis of hiv |
| 04/01/2004 | WO2004027065A2 Enone reductase gene and microbial production of levodione |
| 04/01/2004 | WO2004027064A2 Ghrh analogues |
| 04/01/2004 | WO2004027063A1 Use of sirnas for gene silencing in antigen presenting cells |
| 04/01/2004 | WO2004027062A2 Functional correction of the -786c/t variance of the human enos gene |
| 04/01/2004 | WO2004027060A1 Method of amplifying nucleic acid, reagent kit for amplifying nucleic acid, method of detecting single nucleotide polymorphism and reagent kit for detecting single nucleotide polymorphism |
| 04/01/2004 | WO2004027059A1 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof |
| 04/01/2004 | WO2004027058A1 Method of detecting genes specifying allergy predisposition |
| 04/01/2004 | WO2004027057A1 Method of analyzing organelle-localized protein and materials for analysis |
| 04/01/2004 | WO2004027056A2 Methods of use for thermostable rna ligases |
| 04/01/2004 | WO2004027055A1 Novel carbonyl reductase, gene thereof and method of using the same |
| 04/01/2004 | WO2004027054A1 Thermostable rna ligase from thermus phage |
| 04/01/2004 | WO2004027044A2 Triplex hairpin ribozyme |
| 04/01/2004 | WO2004027043A2 Method for production of a multimeric protein by cell fusion |
| 04/01/2004 | WO2004027038A2 Biological containment system |
| 04/01/2004 | WO2004027035A2 Riboswitches, methods for their use, and compositions for use with riboswitches. |
| 04/01/2004 | WO2004027033A2 Lentiviral vector-mediated gene transfer and uses thereof |
| 04/01/2004 | WO2004027032A2 Stearoyl coa desaturase transgenic non-human animals |
| 04/01/2004 | WO2004027030A2 Efficient reduction of target rna’s by single- and double-stranded oligomeric compounds |
| 04/01/2004 | WO2004027028A2 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 04/01/2004 | WO2004027024A2 Isolation of genetic molecules from a complex biological construct for use in genetic expression analysis |
| 04/01/2004 | WO2004027023A2 Preservation of rna and reverse transcriptase during automated liquid handling |
| 04/01/2004 | WO2004027019A2 Improved raav expression systems for genetic modification of specific capsid proteins |
| 04/01/2004 | WO2004027015A1 Device and method for processing biological material |
| 04/01/2004 | WO2004026907A2 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals |
| 04/01/2004 | WO2004026905A2 Transporter/channel proteins |
| 04/01/2004 | WO2004026903A2 Live antenuated parasite vaccine |
| 04/01/2004 | WO2004026901A1 M. paratuberculosis specific abc-transporter operon |
| 04/01/2004 | WO2004026892A2 Fragmentation of dna |
| 04/01/2004 | WO2004026343A1 Site-specific gene conversion promoter and gene therapeutic |
| 04/01/2004 | WO2004026337A1 Combination treatment of cancer using a cancer vaccine and a chemotherapeutic drug |
| 04/01/2004 | WO2004026285A2 Compositions and methods for treating heart disease |
| 04/01/2004 | WO2004026260A2 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | WO2004026240A2 Animal immunocontraceptives expressed in plants and uses thereof |
| 04/01/2004 | WO2004026238A2 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers |
| 04/01/2004 | WO2004026227A2 A METHOD FOR GENERATION OF A RANDOM RNAi LIBRARY AND ITS APPLICATION IN CELL-BASED SCREENS |
| 04/01/2004 | WO2004026107A2 Kits and methods for assessing skin health |
| 04/01/2004 | WO2004026026A1 7f4 gene transgenic animal |
| 04/01/2004 | WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 04/01/2004 | WO2004016766A3 Real time measurement of cellular responses |
| 04/01/2004 | WO2004016759A3 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 04/01/2004 | WO2004013276A9 Novel tricistronic vectors and uses therefor |
| 04/01/2004 | WO2004009803A3 Regulation of human hepsin |
| 04/01/2004 | WO2004009762A9 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 04/01/2004 | WO2004007723A3 Genes |
| 04/01/2004 | WO2004007694A3 High efficiency germline transformation system |
| 04/01/2004 | WO2004005478A3 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2004 | WO2004005473A3 Hcv fusion proteins with modified ns3 domains |
| 04/01/2004 | WO2004005460A3 Antisense modulation of hmg-coa reductase expression |
| 04/01/2004 | WO2004003153A8 Live replicating spumavirus vector |
| 04/01/2004 | WO2004003014A3 Gene for increased somatic recombination |
| 04/01/2004 | WO2004001034A3 Regulation of gene expression using intron 1 of the ly-6 gene superfamily |
| 04/01/2004 | WO2004001032A3 Stable adenoviral vectors and methods for propagation thereof |
| 04/01/2004 | WO2003106659A3 Aptamer-toxin molecules and methods for using same |
| 04/01/2004 | WO2003106652A3 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
| 04/01/2004 | WO2003106630A3 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |